Desikan Nithya 4
4 · RHYTHM PHARMACEUTICALS, INC. · Filed Aug 13, 2019
Insider Transaction Report
Form 4
Desikan Nithya
Chief Commercial Officer
Transactions
- Exercise/Conversion
Common Stock
2019-08-12$6.88/sh+14,534$99,994→ 29,068 total - Exercise/Conversion
Employee Stock Option (Right to Buy)
2019-08-12−14,534→ 172,676 totalExercise: $6.88Exp: 2027-08-08→ Common Stock (14,534 underlying)
Footnotes (1)
- [F1]The stock options were granted on August 9, 2017. 32,715 of the total shares vested and became exercisable immediately upon grant. 25% of the remaining stock options vested and became exercisable on July 23, 2018. 75% of the remaining stock options shall vest in 36 successive, equal monthly installments with the first such installment vesting and becoming exercisable on August 23, 2018.